Effectiveness of Dry Needling versus Placebo on Gait Performance, Spasticity, Electromyographic Activity, Pain, Range-of-Movement and Quality of Life in Patients with Multiple Sclerosis: A Randomized Controlled Trial Protocol
Autor: | David Lucena-Anton, Alberto Marcos Heredia-Rizo, Guillermo Izquierdo-Ayuso, Jose A. Moral-Munoz, Carlos Luque-Moreno, Anabel Granja-Domínguez |
---|---|
Přispěvatelé: | Enfermería y Fisioterapia, Universidad de Sevilla. Departamento de Fisioterapia, Universidad de Sevilla. Departamento de Medicina |
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Modified Ashworth scale Population Placebo multiple sclerosis lcsh:RC321-571 law.invention 03 medical and health sciences Study Protocol 0302 clinical medicine Physical medicine and rehabilitation Randomized controlled trial Quality of life law medicine 030212 general & internal medicine Spasticity education lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry dry needling muscle spasticity Dry needling education.field_of_study physical therapy modalities gait disorders business.industry General Neuroscience neurologic Gait clinical trial protocol pain management medicine.symptom business 030217 neurology & neurosurgery |
Zdroj: | Brain Sci. 2020, 10(12), 997 RODIN: Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz Universidad de Cádiz Brain Sciences Brain Sciences, Vol 10, Iss 997, p 997 (2020) RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz instname idUS. Depósito de Investigación de la Universidad de Sevilla idUS: Depósito de Investigación de la Universidad de Sevilla Universidad de Sevilla (US) |
ISSN: | 1261-9000 |
Popis: | Dry needling (DN) is an emerging technique commonly used in neurological and musculoskeletal pain conditions, but there have been no previous studies in patients with multiple sclerosis (pwMS). This trial aims to assess the e_cacy of deep DN, compared with sham placebo DN, on gait performance, spasticity level, pain, electromyographic activity, range-of-movement (ROM) and quality of life in pwMS. Forty adults with MS were randomly assigned to one study group. The DN group will undergo 2 sessions (once per week) usingDNover the rectus femoris (RF) and gastrocnemius medialis (GM) muscles at the lower extremity with higher spasticity. The placebo group will receive the same protocol using a sham placebo needle (Dong Bang needle). Outcome measures will include gait performance, using the GaitRite® system, spasticity level with the Modified Ashworth Scale, superficial electromyographic activity of RF and GM, pain (pressure algometer), ROM (goniometer), and quality of life (Musiqol). This study is the first investigating the short-term e_ect of DN, compared with placebo, in pwMS, and taking into account the possible changes in the electromyographic activity of the lower limb. Therefore, the results may help to understand the suitability of using this technique in the clinical setting for this population. Trial registration: ACTRN12619000880145. |
Databáze: | OpenAIRE |
Externí odkaz: |